tradingkey.logo

Bone Biologics Corp <BBLG.OQ> expected to post a loss of 53 cents a share - Earnings Preview

ReutersAug 15, 2025 8:07 PM
  • Bone Biologics Corp BBLG.OQ BBLG.O is expected to show no change in quarterly revenue when it reports results on November 12 (estimated) for the period ending September 30 2025

  • ​LSEG's mean analyst estimate for Bone Biologics Corp is for a loss of 53 cents per share.

  • The mean earnings estimate of analysts had risen by about 78.5% in the last three months. ​

  • Wall Street's median 12-month price target for Bone Biologics Corp is $22.50, about 89.6% above its last closing price of $2.35

This summary was machine generated August 15 at 20:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI